"Informed Altruism" and "Partner Restriction" in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001

Don Des Jarlais, Theresa Perlis, Kamyar Arasteh, Holly Hagan, Judith Milliken, Naomi Braine, Stanley Yancovitz, Donna Mildvan, David C. Perlman, Carey Maslow, Samuel R. Friedman

Research output: Contribution to journalArticle

Abstract

Objective: To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world. Methods: Serial cross-sectional surveys conducted continuously from 1990 to 2001 of IDUs entering the Beth Israel Medical Center (BIMC) drug detoxification program in New York City. HIV serostatus, use of prevention services, and risk behaviors were measured. Individuals were permitted to participate multiple times in the surveys but not more than once in any year. Results: Two thousand eight hundred eighty-seven individuals contributed 3100 observations from 1990 to 2001. There was a substantial and consistent decline in the prevalence of HIV infection among IDUs entering the BIMC detoxification program, from 54% (165/304) in 1991 to 13% (39/303) in 2001 (P < 0.0001). The decline was highly linear, with r2 = 0.92 and a slope of -3.7% in seroprevalence per year. The decline occurred for both males and females, both short and long-term IDUs, and the three largest racial/ethnic sub-groups (all P < 0.001 by Cochran-Armitage testing). Use of HIV prevention services increased substantially, particularly syringe exchange and voluntary HIV counseling and testing. General reductions in injection risk behaviors occurred, but substantial numbers of IDUs continued to engage in both receptive and distributive syringe sharing. Two conditional types of risk reduction not currently recommended by health authorities were reported: "informed altruism," in which persons who knew that they were HIV seropositive reduced transmission behavior, and "partner restriction," in which persons who shared needles and syringes primarily confined this sharing within small social networks. Conclusions: HIV infection continues to decline in this population of IDUs in New York City, suggesting the possibility of bringing very high prevalence epidemics under control. Risk elimination may not be required; rather, multiple forms of risk reduction may be effective in reducing HIV transmission within a local population of IDUs.

Original languageEnglish (US)
Pages (from-to)158-166
Number of pages9
JournalJournal of Acquired Immune Deficiency Syndromes
Volume35
Issue number2
DOIs
StatePublished - Feb 1 2004

Fingerprint

Altruism
Drug Users
HIV Infections
HIV
Therapeutics
Syringes
Israel
Risk Reduction Behavior
Risk-Taking
Acquired Immunodeficiency Syndrome
Needle Sharing
Seroepidemiologic Studies
Ethnic Groups
Social Support
Population
Needles
Counseling
Cross-Sectional Studies
Injections

Keywords

  • AIDS
  • HIV
  • Injecting drug users
  • New York City
  • Risk behaviors
  • Substance abuse

ASJC Scopus subject areas

  • Virology
  • Immunology

Cite this

"Informed Altruism" and "Partner Restriction" in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001. / Des Jarlais, Don; Perlis, Theresa; Arasteh, Kamyar; Hagan, Holly; Milliken, Judith; Braine, Naomi; Yancovitz, Stanley; Mildvan, Donna; Perlman, David C.; Maslow, Carey; Friedman, Samuel R.

In: Journal of Acquired Immune Deficiency Syndromes, Vol. 35, No. 2, 01.02.2004, p. 158-166.

Research output: Contribution to journalArticle

Des Jarlais, Don ; Perlis, Theresa ; Arasteh, Kamyar ; Hagan, Holly ; Milliken, Judith ; Braine, Naomi ; Yancovitz, Stanley ; Mildvan, Donna ; Perlman, David C. ; Maslow, Carey ; Friedman, Samuel R. / "Informed Altruism" and "Partner Restriction" in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001. In: Journal of Acquired Immune Deficiency Syndromes. 2004 ; Vol. 35, No. 2. pp. 158-166.
@article{82c0530c911f4556b60b41a702bf8ad4,
title = "{"}Informed Altruism{"} and {"}Partner Restriction{"} in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001",
abstract = "Objective: To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world. Methods: Serial cross-sectional surveys conducted continuously from 1990 to 2001 of IDUs entering the Beth Israel Medical Center (BIMC) drug detoxification program in New York City. HIV serostatus, use of prevention services, and risk behaviors were measured. Individuals were permitted to participate multiple times in the surveys but not more than once in any year. Results: Two thousand eight hundred eighty-seven individuals contributed 3100 observations from 1990 to 2001. There was a substantial and consistent decline in the prevalence of HIV infection among IDUs entering the BIMC detoxification program, from 54{\%} (165/304) in 1991 to 13{\%} (39/303) in 2001 (P < 0.0001). The decline was highly linear, with r2 = 0.92 and a slope of -3.7{\%} in seroprevalence per year. The decline occurred for both males and females, both short and long-term IDUs, and the three largest racial/ethnic sub-groups (all P < 0.001 by Cochran-Armitage testing). Use of HIV prevention services increased substantially, particularly syringe exchange and voluntary HIV counseling and testing. General reductions in injection risk behaviors occurred, but substantial numbers of IDUs continued to engage in both receptive and distributive syringe sharing. Two conditional types of risk reduction not currently recommended by health authorities were reported: {"}informed altruism,{"} in which persons who knew that they were HIV seropositive reduced transmission behavior, and {"}partner restriction,{"} in which persons who shared needles and syringes primarily confined this sharing within small social networks. Conclusions: HIV infection continues to decline in this population of IDUs in New York City, suggesting the possibility of bringing very high prevalence epidemics under control. Risk elimination may not be required; rather, multiple forms of risk reduction may be effective in reducing HIV transmission within a local population of IDUs.",
keywords = "AIDS, HIV, Injecting drug users, New York City, Risk behaviors, Substance abuse",
author = "{Des Jarlais}, Don and Theresa Perlis and Kamyar Arasteh and Holly Hagan and Judith Milliken and Naomi Braine and Stanley Yancovitz and Donna Mildvan and Perlman, {David C.} and Carey Maslow and Friedman, {Samuel R.}",
year = "2004",
month = "2",
day = "1",
doi = "10.1097/00126334-200402010-00010",
language = "English (US)",
volume = "35",
pages = "158--166",
journal = "Journal of Acquired Immune Deficiency Syndromes",
issn = "1525-4135",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - "Informed Altruism" and "Partner Restriction" in the Reduction of HIV Infection in Injecting Drug Users Entering Detoxification Treatment in New York City, 1990-2001

AU - Des Jarlais, Don

AU - Perlis, Theresa

AU - Arasteh, Kamyar

AU - Hagan, Holly

AU - Milliken, Judith

AU - Braine, Naomi

AU - Yancovitz, Stanley

AU - Mildvan, Donna

AU - Perlman, David C.

AU - Maslow, Carey

AU - Friedman, Samuel R.

PY - 2004/2/1

Y1 - 2004/2/1

N2 - Objective: To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world. Methods: Serial cross-sectional surveys conducted continuously from 1990 to 2001 of IDUs entering the Beth Israel Medical Center (BIMC) drug detoxification program in New York City. HIV serostatus, use of prevention services, and risk behaviors were measured. Individuals were permitted to participate multiple times in the surveys but not more than once in any year. Results: Two thousand eight hundred eighty-seven individuals contributed 3100 observations from 1990 to 2001. There was a substantial and consistent decline in the prevalence of HIV infection among IDUs entering the BIMC detoxification program, from 54% (165/304) in 1991 to 13% (39/303) in 2001 (P < 0.0001). The decline was highly linear, with r2 = 0.92 and a slope of -3.7% in seroprevalence per year. The decline occurred for both males and females, both short and long-term IDUs, and the three largest racial/ethnic sub-groups (all P < 0.001 by Cochran-Armitage testing). Use of HIV prevention services increased substantially, particularly syringe exchange and voluntary HIV counseling and testing. General reductions in injection risk behaviors occurred, but substantial numbers of IDUs continued to engage in both receptive and distributive syringe sharing. Two conditional types of risk reduction not currently recommended by health authorities were reported: "informed altruism," in which persons who knew that they were HIV seropositive reduced transmission behavior, and "partner restriction," in which persons who shared needles and syringes primarily confined this sharing within small social networks. Conclusions: HIV infection continues to decline in this population of IDUs in New York City, suggesting the possibility of bringing very high prevalence epidemics under control. Risk elimination may not be required; rather, multiple forms of risk reduction may be effective in reducing HIV transmission within a local population of IDUs.

AB - Objective: To assess recent developments in the HIV epidemic in injecting drug users (IDUs) in New York City. With >50,000 cases of AIDS in IDUs, New York has experienced the largest HIV/AIDS epidemic in IDUs of any city in the world. Methods: Serial cross-sectional surveys conducted continuously from 1990 to 2001 of IDUs entering the Beth Israel Medical Center (BIMC) drug detoxification program in New York City. HIV serostatus, use of prevention services, and risk behaviors were measured. Individuals were permitted to participate multiple times in the surveys but not more than once in any year. Results: Two thousand eight hundred eighty-seven individuals contributed 3100 observations from 1990 to 2001. There was a substantial and consistent decline in the prevalence of HIV infection among IDUs entering the BIMC detoxification program, from 54% (165/304) in 1991 to 13% (39/303) in 2001 (P < 0.0001). The decline was highly linear, with r2 = 0.92 and a slope of -3.7% in seroprevalence per year. The decline occurred for both males and females, both short and long-term IDUs, and the three largest racial/ethnic sub-groups (all P < 0.001 by Cochran-Armitage testing). Use of HIV prevention services increased substantially, particularly syringe exchange and voluntary HIV counseling and testing. General reductions in injection risk behaviors occurred, but substantial numbers of IDUs continued to engage in both receptive and distributive syringe sharing. Two conditional types of risk reduction not currently recommended by health authorities were reported: "informed altruism," in which persons who knew that they were HIV seropositive reduced transmission behavior, and "partner restriction," in which persons who shared needles and syringes primarily confined this sharing within small social networks. Conclusions: HIV infection continues to decline in this population of IDUs in New York City, suggesting the possibility of bringing very high prevalence epidemics under control. Risk elimination may not be required; rather, multiple forms of risk reduction may be effective in reducing HIV transmission within a local population of IDUs.

KW - AIDS

KW - HIV

KW - Injecting drug users

KW - New York City

KW - Risk behaviors

KW - Substance abuse

UR - http://www.scopus.com/inward/record.url?scp=9144238059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9144238059&partnerID=8YFLogxK

U2 - 10.1097/00126334-200402010-00010

DO - 10.1097/00126334-200402010-00010

M3 - Article

C2 - 14722449

AN - SCOPUS:9144238059

VL - 35

SP - 158

EP - 166

JO - Journal of Acquired Immune Deficiency Syndromes

JF - Journal of Acquired Immune Deficiency Syndromes

SN - 1525-4135

IS - 2

ER -